Acyloxymethyl acidic drug derivatives: in vitro hydrolytic reactivity.
A series of acyloxymethyl drug derivatives of the NH-acidic drugs, phenytoin and theophylline and of the carboxylic acid drugs, thioctic acid and indomethacin, were prepared in order to determine the effect of varying the nature of the drug on the in vitro rate of hydrolysis catalyzed by porcine liver esterase and human plasma. The acyl portion was comprised of either valeric acid (val) or gamma-linolenic acid (GLA). With the exception of some GLA prodrugs, the derivatives displayed first-order kinetics in both enzyme systems. The NH-acidic drug derivatives were hydrolyzed faster than the carboxylic drug derivatives by porcine liver esterase and human plasma. It was found that the short chain valeric acid derivatives were hydrolyzed faster than the GLA derivatives. The rates of hydrolysis for the relatively smaller prodrugs of theophylline and thioctic acid were greater than the rates of hydrolysis for the bulkier phenytoin and indomethacin prodrugs indicating steric hindrance was important. The lipophilicity index, log K, of the valeric acid drug derivatives was plotted against the logarithm of the hydrolysis rate constant, k, and it was observed that log k decreased with an increase in log K. A comparison of these results with those of previous studies where the alkyl and acyl moieties were varied of acyloxyalkyl theophylline derivatives has provided a rationale, based on lipophilicity, for the structure of a prodrug to be designed based on an in vitro desired rate of hydrolysis.
Redden
P R
PR
Scotia Research Institute, P.O. Box 818, Kentville, NS, B4N 4H8, Canada. srins@istar.ca
Melanson
R L
RL
Douglas
J A
JA
Dick
A J
AJ
D000818:Animals; D002851:Chromatography, High Pressure Liquid; D004950:Esterases / Q000097:blood / Q000378:metabolism; D006801:Humans; D006868:Hydrolysis; D007213:Indomethacin / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics; D007700:Kinetics; D008099:Liver / Q000201:enzymology; D010421:Pentanoic Acids / Q000097:blood / Q000493:pharmacokinetics*; D010672:Phenytoin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics; D011355:Prodrugs / Q000138:chemical synthesis / Q000378:metabolism / Q000493:pharmacokinetics*; D013329:Structure-Activity Relationship; D013552:Swine; D013806:Theophylline / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics; D017965:gamma-Linolenic Acid / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics*
D010421:Pentanoic Acids; D011355:Prodrugs; D010672:Phenytoin; D017965:gamma-Linolenic Acid; D013806:Theophylline; D004950:Esterases; C038780:n-pentanoic acid; D007213:Indomethacin